6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Challenges and Future Directions in Regenerative Medicine
Despite its promise, the field faces scientific, logistical, and regulatory hurdles. Challenges and future directions in regenerative medicine include issues like limited vascularization, immune rejection, ethical concerns, and scaling up production without compromising quality. As researchers overcome these barriers, future directions point toward integrating AI, robotics, and smart biomaterials for more responsive and adaptive therapies. Standardizing clinical trial design, ensuring equitable access, and aligning global regulations are also key to realizing the full potential of the field. Challenges and future directions in regenerative medicine remain central to the ongoing dialogue among scientists, clinicians, and policymakers striving to make advanced therapies safe, effective, and widely available.
Marco Polettini
DVM, Italy
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United KingdomSubmit your abstract Today
Title :
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title :
Marco Polettini, DVM, Italy
Title :
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Personalized and Precision Medicine PPM as a unique healthcare model via pathology related modeling biodesign inspired translational applications and clinical practice of the next step generation to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation